Admenta 5 Tablet

USDailyMed:Memantine AU:B2 N06DX01(WHO) AU:S4(Prescription only)BR:Class C1(Other controlled substances)UK:POM(Prescription only)US:℞-onlyEU:Rx-only 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine 19982-08-2Yas HCl:41100-52-1 4054as HCl:181458 4253 DB01043Yas HCl:DBSALT000456 3914Yas HCl:157849 W8O17SJF3Tas HCl:JY0WD0UA60 D08174Yas HCl:D04905 CHEBI:64312as HCl:CHEBI:64323 ChEMBL807Yas HCl:ChEMBL1699 377 (PDBe,RCSB PDB) DTXSID5045174 Interactive imageas HCl:Interactive image NC12CC3CC(C)(C1)CC‍‍‍‍‍‍​​​‍​​​​​​(C)(C3)C2as HCl: Cl.NC12CC3CC(C)(C1)CC(C)(C3)C2 InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3YKey:BUGYDGFZZOZRHP-UHFFFAOYSA-NYas HCl: InChI=1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1HKey:LDDHMLJTFXJGPI-UHFFFAOYSA-N Memantine, sold under the brand nameNamendaamong others, is a medication used to slow the progression of moderate-to-severeAlzheimer's disease.It is takenby mouth. Commonside effectsincludeheadache,constipation,sleepiness, anddizziness.Severe side effects may includeblood clots,psychosis, andheart failure.It is believed to work by acting onNMDA receptors, working as apore blockerof theseion channels. Memantine was first discovered in 1963.It was approved for medical use inGermanyin 1989, in theEuropean Unionin 2002, and in theUnited Statesin 2003.It is available as ageneric medication.In 2023, it was the 145th most commonly prescribed medication in the United States, with more than 3million prescriptions.